ACTA1 and pulmonary fibrosis: Deletion of the miR-301a gene in experimental mice led to reduced expression of vimentin, α-SMA, and fibronectin, thereby mitigating the severity of pulmonary fibrosis following BLM injection and suppressing the proliferation and activation of pulmonary fibroblasts (Wang J. et al., 2020).